| pubmed-article:9316697 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9316697 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:9316697 | lifeskim:mentions | umls-concept:C0016293 | lld:lifeskim |
| pubmed-article:9316697 | lifeskim:mentions | umls-concept:C0221169 | lld:lifeskim |
| pubmed-article:9316697 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:9316697 | pubmed:dateCreated | 1997-10-23 | lld:pubmed |
| pubmed-article:9316697 | pubmed:abstractText | Three patients with hemiballismus received intravenous flumazenil and placebo in a double-blind cross-over study aimed to investigate whether an antagonistic action at the level of the GABA-benzodiazepine receptors may improve choreoballistic movements. No clinical benefit was seen. | lld:pubmed |
| pubmed-article:9316697 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9316697 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9316697 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9316697 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9316697 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9316697 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9316697 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9316697 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:9316697 | pubmed:issn | 0362-5664 | lld:pubmed |
| pubmed-article:9316697 | pubmed:author | pubmed-author:AvilaAA | lld:pubmed |
| pubmed-article:9316697 | pubmed:author | pubmed-author:KulisevskyJJ | lld:pubmed |
| pubmed-article:9316697 | pubmed:author | pubmed-author:BerthierM LML | lld:pubmed |
| pubmed-article:9316697 | pubmed:author | pubmed-author:BarbanojMM | lld:pubmed |
| pubmed-article:9316697 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9316697 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:9316697 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9316697 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9316697 | pubmed:pagination | 470-2 | lld:pubmed |
| pubmed-article:9316697 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:9316697 | pubmed:meshHeading | pubmed-meshheading:9316697-... | lld:pubmed |
| pubmed-article:9316697 | pubmed:meshHeading | pubmed-meshheading:9316697-... | lld:pubmed |
| pubmed-article:9316697 | pubmed:meshHeading | pubmed-meshheading:9316697-... | lld:pubmed |
| pubmed-article:9316697 | pubmed:meshHeading | pubmed-meshheading:9316697-... | lld:pubmed |
| pubmed-article:9316697 | pubmed:meshHeading | pubmed-meshheading:9316697-... | lld:pubmed |
| pubmed-article:9316697 | pubmed:meshHeading | pubmed-meshheading:9316697-... | lld:pubmed |
| pubmed-article:9316697 | pubmed:meshHeading | pubmed-meshheading:9316697-... | lld:pubmed |
| pubmed-article:9316697 | pubmed:meshHeading | pubmed-meshheading:9316697-... | lld:pubmed |
| pubmed-article:9316697 | pubmed:meshHeading | pubmed-meshheading:9316697-... | lld:pubmed |
| pubmed-article:9316697 | pubmed:meshHeading | pubmed-meshheading:9316697-... | lld:pubmed |
| pubmed-article:9316697 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:9316697 | pubmed:articleTitle | Double-blind trial of flumazenil in hemiballismus. | lld:pubmed |
| pubmed-article:9316697 | pubmed:affiliation | Department of Neurology, Sant Pau Hospital, Autonomous University of Barcelona, Spain. | lld:pubmed |
| pubmed-article:9316697 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9316697 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9316697 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
